Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on June 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

PHARM MANUF/DISTR DIV - FSA

Closed
SPE2D2-26-R-0004Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The solicitation for Lisdexamfetamine Dimesylate Capsules, identified by number SPE2D2-26-R-0004, is issued by the Defense Logistics Agency Troop Support under the Department of Defense for the procurement of pharmaceutical products in multiple strengths and pack sizes, including 10 mg through 70 mg capsules in both 90- and 100-count bottles. Offers are due by 7:00 PM ET on July 28, 2026, following Amendment 0002 which extended the original deadline. The contract follows a Lowest Price Technically Acceptable (LPTA) evaluation method where proposals must pass two mandatory technical gates: acceptable ratings for both Technical Requirements and Past Performance, with award going to the offeror meeting these thresholds at the lowest aggregate price. The product must comply with stringent packaging and labeling standards, including the use of non-glass containers with childproof caps, a minimum 100cc cylindrical bottle size with a 5.75-inch circumference, and barcodes adhering to GS1-128 or HIBC standards with grade C or better quality, clearly displaying lot number and expiration date. All products require an FDA-approved NDA or ANDA, precise Country of Origin disclosures for both the final product and active pharmaceutical ingredient under the Trade Agreements Act, and unique eleven-digit NDC codes. Delivery is FOB Destination to DLA and VA Pharmaceutical Prime Vendors, with performance readiness required within 45 days of award and pricing becoming effective 15 days after performance start. Contractors must establish business-to-business agreements with PPV vendors for payment, delivery, and chargeback terms, receiving payment indirectly through these vendors rather than directly from the government, and are prohibited from assigning payment rights. The contract includes cost recovery fees of 0.5 percent, payable via Cashlink ACH or Pay.gov using specific identification codes. Compliance is governed by numerous FAR and DFARS clauses including prohibitions on gratuities, subcontractor sales restrictions, contractor ethics, cybersecurity, and telecommunications equipment restrictions, as well as SAM registration and representation certifications that must be current and submitted electronically. Proposals must be submitted exclusively via the DIBBS system with separate non-price and price volumes containing all required documentation, and inclusion of marketing materials is prohibited. The solicitation may proceed to a Reverse Auction after initial evaluation, and all terms bind the contractor to federal procurement regulations under the NAICS code 3254

General Info

DLA seeks suppliers for Lisdexamfetamine capsules, firm-fixed price, one-year base plus four option years.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

PA, USA

Set-Aside

NONE

Documents

7

Amendment 0001 to Solicitation SPE2D226R0004

PDF, High priority: read this firstamendment
High

Amendment 0001 to Solicitation SPE2D226R0004

PDF, High priority: read this firstamendment
High

Amendment 0002 to Solicitation SPE2D226R0004

PDF, High priority: read this firstamendment
High

Amendment 0002 to Solicitation SPE2D226R0004

PDF, High priority: read this firstamendment
High

Solicitation SPE2D2-26-R-0004 for Commercial Items

PDF, High priority: read this firstrfp
High

Solicitation SPE2D2-26-R-0004 for Commercial Items

PDF, High priority: read this firstrfq
High

Solicitation SPE2D2-26-R-0004 for Lisdexamfetamine

PDF, High priority: read this firstrfp
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Notice updated

Response deadline changed from Jul 2, 2026 to Jul 14, 2026. The notice description changed.

Notice updated

Response deadline changed from Jul 14, 2026 to Jul 28, 2026. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN FSGB
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts
Courtney Hunter

Full Description

Show more
PHARM MANUF/DISTR DIV - FSA NSN/Part Number: 3RFQ3SEESOW

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN FSGB

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS